Peptidyl Arginine Deiminase, Type II (PADI2) Antikörper

Antigen: Peptidyl Arginine Deiminase, Type II (PADI2)

Synonyme: PAD2, PDI2, PAD-H19, KIAA0994, Pdi, Pdi2, mKIAA0994, PADI2, MGC152140

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human, Ratte (Rattus), Maus

Applikation: ELISA, Immunhistochemie (IHC), Immunpräzipitation (IP), Western Blot (WB)

Produktnummer: ABIN347065

Produktbeschreibung

Weitere Bezeichnung: Peptidylarginine deiminase type II (PAD-2)

Immunogen: A15 residue synthetic peptide derived from C-terminal domain

Format: Antiserum

Spezifität: Antiserum reacts specifically with 76 kDa of PAD2 protein from human, mouse and rat. Cross Reactivities: There is no cross reaction with the other isoforms

Anwendungen

Applikationshinweise: Optimal dilutions should be determined by the end user.The following are guidelines only: ELISA : 1/1 000 to 1/5 000. Immunohistochemistry : 1/50 to 1/100. Immunoprecipitation :1/20 to 1/100. Western Blot : 1/200 to 1/2 000

Buffer: Lyophilized from 100 µl of serum. Preservative: None.

Lagerung: Short term storage: +4°C. Long term storage: -20°C

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Bhattacharya, Crabb, Bonilha et al.: "Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis." in: Investigative ophthalmology & visual science, Vol. 47, Issue 6, pp. 2508-14, 2006 (PubMed).